[Cell-based approaches to promote bone regeneration in distraction osteogenesis]
- PMID: 23316648
[Cell-based approaches to promote bone regeneration in distraction osteogenesis]
Abstract
Objective: To summarize the recent progress of cell-based approaches for promoting bone regeneration in distraction osteogenesis (DO).
Methods: Recent literature concerning enhancement of bone regeneration following DO using cell-based approaches was reviewed and analyzed.
Results: An overview of 4 different cell-based approaches was mainly provided: single cell injection, cell scaffold-based strategies/injectable tissue engineered bone, microtissue technology or cell aggregate technology, and stem cell gene therapy. Each has its advantages and disadvantages. Other methods are still in the experimental research except that compound injection of bone marrow mesechymal stem cells and platelet-rich plasma has been applied to clinical practice.
Conclusion: The cell-based approach is a promising strategy in the field of bone regenerative medicine. These approaches have bright future in promoting bone regeneration and reducing the treatment period in DO in the clinical application. However, well-designed preclinical studies are required to establish safe and effective guidelines for cell-based approaches to promoting bone regeneration during DO.
Similar articles
-
Promoted new bone formation in maxillary distraction osteogenesis using a tissue-engineered osteogenic material.J Craniofac Surg. 2008 Jan;19(1):80-7. doi: 10.1097/scs.0b013e31815c93e3. J Craniofac Surg. 2008. PMID: 18216669
-
Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering.J Craniofac Surg. 2009 Sep;20(5):1523-30. doi: 10.1097/SCS.0b013e3181b09b7e. J Craniofac Surg. 2009. PMID: 19816290
-
bFGF-Modified BMMSCs enhance bone regeneration following distraction osteogenesis in rabbits.Bone. 2010 Apr;46(4):1156-61. doi: 10.1016/j.bone.2009.12.017. Epub 2009 Dec 28. Bone. 2010. PMID: 20036345
-
The use of bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for alveolar bone tissue engineering: basic science to clinical translation.Tissue Eng Part B Rev. 2014 Jun;20(3):229-32. doi: 10.1089/ten.TEB.2013.0578. Epub 2014 Mar 6. Tissue Eng Part B Rev. 2014. PMID: 24494719 Review.
-
[Cell sheet technology and its application in bone tissue engineering].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Sep;26(9):1122-5. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012. PMID: 23057362 Review. Chinese.
Cited by
-
Stem and progenitor cells: advancing bone tissue engineering.Drug Deliv Transl Res. 2016 Apr;6(2):159-73. doi: 10.1007/s13346-015-0235-1. Drug Deliv Transl Res. 2016. PMID: 25990836 Free PMC article. Review.